Armed with CRISPR and a $38M round, eGe­n­e­sis tack­les the Holy Grail of xeno­trans­plan­ta­tion

The first crude re­search in­volv­ing xeno­trans­plan­ta­tion goes back to the 1960s, when in­ves­ti­ga­tors first ac­tive­ly con­sid­ered the pos­si­bil­i­ties of har­vest­ing or­gans from pri­mates for use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER